Berkman Charles S insider trades
Berkman Charles S has filed 27 Form 4s with the SEC that we hold, for OmniAb, Inc. (OABI) (Chief Legal Officer), Ligand Pharmaceuticals INC (LGND) (Reporting owner) and CIK 1893653 (CLO & Secretary, Director). Across all of them we count 0 purchases worth $0 and 10 sales worth $278.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($54.9K). The largest single trade was a sale of 25,489 shares of OmniAb, Inc. worth $82.6K, dated 2025-01-21. The first filing on our record is dated 2022-01-28 and the latest 2026-04-07.
OmniAb, Inc. (OABI)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-04-08 | S, sale reported on Form 4 | 6,954 | $36.6K | 2024-04-09 | SEC |
| 2024-12-09 | S, sale reported on Form 4 | 8,022 | $33.1K | 2024-12-10 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 25,489 | $82.6K | 2025-01-22 | SEC |
| 2025-02-18 | S, sale reported on Form 4 | 8,215 | $30.2K | 2025-02-19 | SEC |
| 2025-02-19 | S, sale reported on Form 4 | 7,255 | $26.6K | 2025-02-19 | SEC |
| 2025-04-07 | S, sale reported on Form 4 | 7,206 | $14.4K | 2025-04-07 | SEC |
| 2025-12-08 | S, sale reported on Form 4 | 8,044 | $15.8K | 2025-12-09 | SEC |
| 2026-02-17 | S, sale reported on Form 4 | 6,990 | $11.9K | 2026-02-17 | SEC |
| 2026-02-18 | S, sale reported on Form 4 | 9,673 | $16.5K | 2026-02-18 | SEC |
| 2026-04-07 | S, sale reported on Form 4 | 7,157 | $10.7K | 2026-04-07 | SEC |
Ligand Pharmaceuticals INC (LGND)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CIK 1893653
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1392266) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
